Medicare Benefits Schedule - Item 73813

Detection performed by, or on behalf of, a medical practitioner of:

(a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and

(b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection

Fee: $117.65 Benefit: 85% = $100.05

(See para PR.9.5 of explanatory notes to this Category)

• Previous - Item 73812
• Next - Item 73825

Item 73813 applies to a service only if:

(a) the service is rendered at, or from, a practice location in:

(i) a Modified Monash 6 area; or

(ii) a Modified Monash 7 area;

(b) the medical practitioner providing the service, or the health professional providing the service on behalf of a medical practitioner, is employed by an organisation that:

(i) delivers health services; and

(ii) is participating in the First Nations Molecular Point-of-Care (PoC) Testing Program;

(c) the service is provided in accordance with the Program referred to in subparagraph (b)(ii);

(d) the service is conducted by a medical practitioner, or on behalf of a medical practitioner by a health professional, who has achieved competency as a PoC operator by the First Nations Molecular PoC Testing Program for the test(s) performed;

(e) the PoC test(s) gives valid patient result(s).

Related Items: 73813